文献速递神经肿瘤

经管状牵开器对深部高级别胶质瘤行手术减瘤

Surgical cytoreduction of deep-seated high-grade glioma through tubular retractor.
PubMed 文献 · J Neurosurg · 2022-11-04

回顾性分析单术者使用管状牵开器对20例深部半球高级别胶质瘤患者行22次切除,中位切除程度93%,中位总生存14.4个月,认为此类深部肿瘤可经管状牵开器切除且安全可接受。

要点

  • 深部高级别胶质瘤经管状牵开器切除的中位切除程度为93%。
  • 全部患者及新诊断IDH野生型胶质母细胞瘤组中位总生存均为14.4个月。
  • 术后2例(10%)出现颞角陷闭需行脑室腹腔分流。

核心结论

  • 深部高级别胶质瘤手术困难且常被认为不可手术,但可经管状牵开器切除,安全性可接受。
  • 此类减瘤手术可能使患者获得与更表浅肿瘤相当的总生存。

研究设计与样本

  • 回顾性综述,纳入20例连续患者共22次深部半球高级别胶质瘤切除,均由单一术者使用Viewsite Brain Access System完成。
  • 记录患者人口学、生存、肿瘤特征、切除程度和神经功能结局;依据弥散张量成像提取的白质束相对位置设计穿刺轨迹和计划切除体积。
  • 手术计划在Brainlab系统设计,术前在Surgical Theater虚拟现实SNAP平台可视化;切除程度在Brainlab平台行体积评估并由认证神经放射科医师确认。

主要发现

  • 20例成人患者包括18例IDH野生型胶质母细胞瘤和2例IDH突变型4级星形细胞瘤,共22次手术。
  • 队列包括新诊断肿瘤17例(77%)和复发肿瘤5例(23%),多数肿瘤(64%)毗邻脑室系统。
  • 术前和术后平均肿瘤体积分别为33.1±5.3 cm3和15.2±5.1 cm3,中位切除程度为93%。
  • 手术并发症包括2例(10%)颞角陷闭需行脑室腹腔分流,1例(5%)伤口感染和肺栓塞,1例(5%)肺炎。
  • 2例(9%)出现新发永久性视野缺损,5例(23%)术前缺损加重;术前神经或认知缺损9例(41%)保持不变,7例(32%)改善。

临床怎么用

  • 作者认为,深部高级别胶质瘤可经管状牵开器行减瘤切除,安全性可接受,并可能获得与更表浅肿瘤相当的总生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Maximal safe resection is the goal of surgical treatment for high-grade glioma (HGG). Deep-seated hemispheric gliomas present a surgical challenge due to safety concerns and previously were often considered inoperable. The authors hypothesized that use of tubular retractors would allow resection of deep-seated gliomas with an acceptable safety profile. The purpose of this study was to describe surgical outcomes and survival data after resection of deep-seated HGG with stereotactically placed tubular retractors, as well as to discuss the technical advances that enable such procedures. METHODS: This is a retrospective review of 20 consecutive patients who underwent 22 resections of deep-seated hemispheric HGG with the Viewsite Brain Access System by a single surgeon. Patient demographics, survival, tumor characteristics, extent of resection (EOR), and neurological outcomes were recorded. Cannulation trajectories and planned resection volumes depended on the relative location of white matter tracts extracted from diffusion tractography. The surgical plans were designed on the Brainlab system and preoperatively visualized on the Surgical Theater virtual reality SNAP platform. Volumetric assessment of EOR was obtained on the Brainlab platform and confirmed by a board-certified neuroradiologist. RESULTS: Twenty adult patients (18 with IDH-wild-type glioblastomas and 2 with IDH-mutant grade IV astrocytomas) and 22 surgeries were included in the study. The cohort included both newly diagnosed (n = 17; 77%) and recurrent (n = 5; 23%) tumors. Most tumors (64%) abutted the ventricular system. The average preoperative and postoperative tumor volumes measured 33.1 ± 5.3 cm3 and 15.2 ± 5.1 cm3, respectively. The median EOR was 93%. Surgical complications included 2 patients (10%) who developed entrapment of the temporal horn, necessitating placement of a ventriculoperitoneal shunt; 1 patient (5%) who suffered a wound infection and pulmonary embolus; and 1 patient (5%) who developed pneumonia. In 2 cases (9%) patients developed new permanent visual field deficits, and in 5 cases (23%) patients experienced worsening of preoperative deficits. Preoperative neurological or cognitive deficits remained the same in 9 cases (41%) and improved in 7 (32%). The median overall survival was 14.4 months in all patients (n = 20) and in the newly diagnosed IDH-wild-type glioblastoma group (n = 16). CONCLUSIONS: Deep-seated HGGs, which are surgically challenging and frequently considered inoperable, are amenable to resection through tubular retractors, with an acceptable safety profile. Such cytoreductive surgery may allow these patients to experience an overall survival comparable to those with more superficial tumors.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hajtovic S, Sun J, Multani JS, et al. Surgical cytoreduction of deep-seated high-grade glioma through tubular retractor. J Neurosurg. 2022. PMID: 36334293. doi:10.3171/2022.9.JNS22842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。